| | Publication Year | Title | Author(s) |
| 1 | 22-Jun-2013 | Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis. | Grace, Josephine A ; Klein, Sabine; Herath, Chandana B; Granzow, Michaela; Schierwagen, Robert; Masing, Noemi; Walther, Thomas; Sauerbruch, Tilman; Burrell, Louise M ; Angus, Peter W ; Trebicka, Jonel |
| 2 | 14-Sep-2009 | Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. | Lubel, John S; Herath, Chandana B; Tchongue, Jorge; Grace, Josephine A ; Jia, Zhiyuan; Spencer, Karen; Casley, David J; Crowley, Peter; Sievert, William; Burrell, Louise M ; Angus, Peter W |
| 3 | 1-Feb-2013 | Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment. | Grace, Josephine A ; Angus, Peter W |
| 4 | Sep-2020 | Proposed mechanism for increased COVID‑19 mortality in patients with decompensated cirrhosis | Grace, Josephine A ; Casey, Stephen ; Burrell, Louise M ; Angus, Peter W |
| 5 | 15-Feb-2013 | Therapeutic potential of targeting the renin angiotensin system in portal hypertension. | Herath, Chandana B; Grace, Josephine A ; Angus, Peter W |
| 6 | 1-Aug-2012 | Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options. | Grace, Josephine A ; Herath, Chandana B; Mak, Kai Yan; Burrell, Louise M ; Angus, Peter W |